Andreas Unterberg Selected Research

Amides

10/2023	Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.
8/2023	Post-Surgical Depositions of Blood Products Are No Major Confounder for the Diagnostic and Prognostic Performance of CEST MRI in Patients with Glioma.
1/2023	CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T.
9/2019	Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
11/2018	Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Unterberg Research Topics

Disease

65	Neoplasms (Cancer) 01/2024 - 03/2006
39	Glioma (Gliomas) 03/2024 - 04/2006
39	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 03/2006
15	Astrocytoma (Pilocytic Astrocytoma) 06/2023 - 10/2009
11	Meningioma (Meningiomas) 12/2023 - 03/2008
11	Brain Neoplasms (Brain Tumor) 01/2023 - 06/2010
7	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2023 - 01/2012
6	Neuralgia (Stump Neuralgia) 01/2022 - 03/2006
5	Contusions 08/2023 - 01/2020
4	Infarction (Infarctions) 02/2024 - 01/2007
4	Necrosis 01/2024 - 01/2019
4	Gliosis 05/2023 - 01/2020
4	Spinal Cord Injuries (Spinal Cord Injury) 05/2023 - 01/2020
4	Pain (Aches) 01/2023 - 10/2017
4	Oligodendroglioma 12/2022 - 10/2009
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 04/2022 - 01/2013
3	Intracranial Hypertension 01/2022 - 01/2007
3	Hematoma 09/2015 - 08/2000
3	Stroke (Strokes) 10/2014 - 06/2010
2	Neuroinflammatory Diseases 08/2023 - 01/2021
2	Infections 03/2023 - 08/2021
2	Chronic Pain 01/2023 - 12/2018
2	Edema (Dropsy) 01/2023 - 06/2003
2	Seizures (Absence Seizure) 01/2023 - 10/2019
2	Spinal Cord Compression 12/2021 - 01/2020
2	Hydrocephalus (Hydrocephaly) 12/2020 - 11/2020
2	Wounds and Injuries (Trauma) 01/2020 - 09/2015
2	Brain Injuries (Brain Injury) 12/2016 - 01/2013
2	Medulloblastoma 01/2016 - 08/2012
2	Thromboembolism 02/2011 - 06/2003
1	Postoperative Hemorrhage 03/2024
1	Hypothermia 01/2024

Drug/Important Bio-Agent (IBA)

14	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 10/2009
14	Proteins (Proteins, Gene)FDA Link 12/2022 - 06/2010
9	Protons (Proton)IBA 10/2023 - 09/2010
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2015
7	APTIBA 10/2023 - 06/2018
7	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 06/2015
7	Messenger RNA (mRNA)IBA 11/2021 - 12/2011
6	RNA (Ribonucleic Acid)IBA 12/2020 - 08/2012
6	AntigensIBA 01/2018 - 01/2008
6	ErbB Receptors (EGF Receptor)IBA 07/2009 - 04/2006
5	CarbonIBA 12/2023 - 09/2010
5	AmidesIBA 10/2023 - 11/2018
5	Temozolomide (Temodar)FDA LinkGeneric 08/2021 - 09/2010
5	Oxygen (Dioxygen)IBA 01/2020 - 12/2010
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2016 - 05/2010
5	Tyrosine Kinase InhibitorsIBA 08/2009 - 04/2006
4	MethyltransferasesIBA 06/2023 - 01/2018
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2009 - 04/2006
3	salicylhydroxamic acid (SHAM)IBA 05/2023 - 12/2021
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2018
3	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2013
3	Peptides (Polypeptides)IBA 01/2018 - 06/2010
3	EnzymesIBA 01/2017 - 03/2006
2	Bevacizumab (Avastin)FDA Link 12/2023 - 03/2014
2	Interleukin-4 (Interleukin 4)IBA 08/2023 - 01/2022
2	tyrosine receptor (receptor, tyrosine)IBA 01/2023 - 11/2021
2	MicroRNAs (MicroRNA)IBA 03/2021 - 06/2015
2	KinesinsIBA 01/2021 - 04/2019
2	4-amino-tetrahydrobiopterinIBA 12/2020 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 10/2016
2	EpitopesIBA 01/2018 - 12/2011
2	LigandsIBA 12/2017 - 04/2006
2	Codon (Codons)IBA 01/2017 - 08/2012
2	RetinoidsIBA 10/2015 - 05/2011
2	Carrier Proteins (Binding Protein)IBA 10/2012 - 05/2011
2	CytokinesIBA 07/2011 - 05/2006
2	NestinIBA 03/2011 - 02/2011
2	IonsIBA 11/2010 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2008 - 05/2006
1	GadoliniumIBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 11/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2023
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 11/2023
1	5- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA 11/2023
1	pexidartinibIBA 11/2023
1	AcidsIBA 06/2023

Therapy/Procedure

34	Therapeutics 08/2023 - 05/2006
17	Radiotherapy 12/2023 - 03/2010
7	Drug Therapy (Chemotherapy) 01/2021 - 10/2010
6	Spinal Cord Stimulation 01/2023 - 07/2006
5	Decompressive Craniectomy 10/2023 - 01/2014
5	Surgical Instruments (Clip) 01/2023 - 06/2003
5	Heavy Ion Radiotherapy 11/2018 - 03/2010
4	Conservative Treatment 02/2024 - 01/2007
4	Craniotomy 03/2023 - 01/2022
4	Immunotherapy 10/2020 - 06/2010
3	Reoperation 03/2024 - 12/2020
3	Electrodes (Electrode) 01/2024 - 03/2006
3	Laminectomy 05/2023 - 01/2020
3	Deep Brain Stimulation 10/2019 - 10/2017
3	Critical Care (Surgical Intensive Care) 01/2013 - 06/2010
2	Transplantation 01/2022 - 01/2020
2	Cell Transplantation 12/2021 - 01/2020
2	Aftercare (After-Treatment) 07/2021 - 12/2017
2	Re-Irradiation 11/2018 - 10/2010
2	Chemoradiotherapy 01/2016 - 09/2010